John Brenner Levine, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Isolation | 5 | 2012 | 362 | 1.380 |
Why?
|
| Genes, Immediate-Early | 2 | 2007 | 102 | 0.560 |
Why?
|
| Wound Healing | 3 | 2011 | 2783 | 0.460 |
Why?
|
| Housing, Animal | 1 | 2011 | 47 | 0.390 |
Why?
|
| Relaxation Therapy | 1 | 2011 | 179 | 0.350 |
Why?
|
| Autistic Disorder | 2 | 2011 | 1216 | 0.340 |
Why?
|
| Prefrontal Cortex | 4 | 2011 | 2209 | 0.340 |
Why?
|
| Yoga | 1 | 2011 | 281 | 0.290 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2007 | 36 | 0.290 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.270 |
Why?
|
| Thalamus | 1 | 2012 | 1040 | 0.260 |
Why?
|
| Child Behavior | 1 | 2011 | 847 | 0.260 |
Why?
|
| Environment | 1 | 2011 | 1118 | 0.250 |
Why?
|
| Oxytocin | 1 | 2009 | 401 | 0.240 |
Why?
|
| Locomotion | 1 | 2007 | 387 | 0.230 |
Why?
|
| Individuation | 2 | 1994 | 23 | 0.230 |
Why?
|
| Behavior, Animal | 2 | 2009 | 1867 | 0.230 |
Why?
|
| Dystonia | 1 | 2007 | 366 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8144 | 0.210 |
Why?
|
| Antipsychotic Agents | 2 | 2007 | 3060 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1419 | 0.190 |
Why?
|
| Functional Laterality | 1 | 2008 | 2252 | 0.190 |
Why?
|
| Hippocampus | 2 | 2012 | 3736 | 0.180 |
Why?
|
| Social Environment | 3 | 2011 | 1022 | 0.180 |
Why?
|
| Clozapine | 1 | 2003 | 506 | 0.170 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1176 | 0.160 |
Why?
|
| Oocytes | 1 | 2003 | 1165 | 0.150 |
Why?
|
| Rats | 8 | 2012 | 23681 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 892 | 0.150 |
Why?
|
| Motor Activity | 1 | 2007 | 2686 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2012 | 6570 | 0.140 |
Why?
|
| MMPI | 5 | 1987 | 81 | 0.130 |
Why?
|
| Animals, Newborn | 3 | 2012 | 2673 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3602 | 0.130 |
Why?
|
| Nerve Degeneration | 1 | 1999 | 748 | 0.120 |
Why?
|
| Motor Neurons | 1 | 1999 | 864 | 0.120 |
Why?
|
| Personality Tests | 1 | 1994 | 81 | 0.120 |
Why?
|
| Personality Inventory | 3 | 1993 | 1018 | 0.110 |
Why?
|
| Anxiety, Separation | 1 | 1994 | 86 | 0.110 |
Why?
|
| Dementia | 1 | 2008 | 2650 | 0.110 |
Why?
|
| Depression | 2 | 2008 | 8057 | 0.110 |
Why?
|
| Personality Assessment | 4 | 1994 | 650 | 0.110 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.100 |
Why?
|
| Astrocytes | 1 | 1999 | 1337 | 0.100 |
Why?
|
| Personality Disorders | 5 | 1987 | 721 | 0.090 |
Why?
|
| Sertraline | 1 | 2011 | 208 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4567 | 0.090 |
Why?
|
| Music Therapy | 1 | 2011 | 110 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11894 | 0.080 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1998 | 1489 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1999 | 1463 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3774 | 0.080 |
Why?
|
| Meditation | 1 | 2011 | 251 | 0.080 |
Why?
|
| Burns | 2 | 2011 | 1848 | 0.080 |
Why?
|
| Extinction, Psychological | 1 | 2011 | 371 | 0.080 |
Why?
|
| Ectoderm | 1 | 2008 | 137 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2008 | 304 | 0.070 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2007 | 20 | 0.070 |
Why?
|
| Animals | 12 | 2012 | 167777 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 60 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 200 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2008 | 230 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 795 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 700 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1520 | 0.060 |
Why?
|
| Estradiol | 1 | 2011 | 1933 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 959 | 0.060 |
Why?
|
| Depression, Chemical | 1 | 2003 | 184 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2004 | 0.060 |
Why?
|
| Male | 16 | 2012 | 358742 | 0.050 |
Why?
|
| Microfluidics | 1 | 2008 | 652 | 0.050 |
Why?
|
| Amygdala | 1 | 2011 | 1351 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2011 | 2490 | 0.050 |
Why?
|
| Psychometrics | 8 | 2004 | 3050 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 8946 | 0.050 |
Why?
|
| Fear | 1 | 2011 | 1462 | 0.050 |
Why?
|
| Receptor, trkA | 1 | 2003 | 159 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2003 | 198 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4169 | 0.050 |
Why?
|
| Psychiatry | 2 | 2004 | 1690 | 0.050 |
Why?
|
| Patient Readmission | 1 | 1996 | 3261 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 1387 | 0.050 |
Why?
|
| Coronary Disease | 1 | 1996 | 5917 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 931 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1168 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1333 | 0.050 |
Why?
|
| Cell Communication | 1 | 2008 | 1651 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1262 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2075 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1878 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2003 | 942 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2697 | 0.040 |
Why?
|
| Schizophrenia | 1 | 1998 | 6913 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2003 | 965 | 0.040 |
Why?
|
| Vacuoles | 1 | 1999 | 228 | 0.040 |
Why?
|
| Gliosis | 1 | 1999 | 244 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1745 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4106 | 0.040 |
Why?
|
| Mentors | 1 | 2004 | 660 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8554 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2690 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2716 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1988 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2012 | 36285 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6293 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 593 | 0.040 |
Why?
|
| Hospitalization | 1 | 1996 | 10653 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6457 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2004 | 1192 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4341 | 0.030 |
Why?
|
| Child | 4 | 2011 | 79813 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2003 | 1251 | 0.030 |
Why?
|
| Neurites | 2 | 2008 | 390 | 0.030 |
Why?
|
| Female | 13 | 2011 | 390316 | 0.030 |
Why?
|
| Adolescent | 5 | 2011 | 87888 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2009 | 4457 | 0.030 |
Why?
|
| Humans | 19 | 2011 | 758381 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2011 | 4562 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2003 | 1888 | 0.030 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3867 | 0.030 |
Why?
|
| Genotype | 1 | 2007 | 12945 | 0.030 |
Why?
|
| Reference Values | 1 | 1999 | 4919 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14354 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9405 | 0.020 |
Why?
|
| Propionates | 1 | 2011 | 182 | 0.020 |
Why?
|
| Psychophysics | 1 | 2011 | 289 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4937 | 0.020 |
Why?
|
| Mutation | 2 | 2007 | 29915 | 0.020 |
Why?
|
| Mice | 3 | 2008 | 81107 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 42058 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 585 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 365 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2008 | 234 | 0.020 |
Why?
|
| Aging | 1 | 2007 | 8651 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18125 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2004 | 6803 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 177 | 0.020 |
Why?
|
| Phenols | 1 | 2011 | 514 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9518 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 20052 | 0.020 |
Why?
|
| Forecasting | 1 | 1996 | 2920 | 0.020 |
Why?
|
| Mitochondria | 1 | 1999 | 3584 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2008 | 286 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 957 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7843 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 1339 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2008 | 1732 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2004 | 5865 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2003 | 48 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2008 | 716 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 58681 | 0.010 |
Why?
|
| Boston | 1 | 1996 | 9304 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 317 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1996 | 3245 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 120 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2057 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 242 | 0.010 |
Why?
|
| Adult | 7 | 2011 | 219916 | 0.010 |
Why?
|
| Time Factors | 3 | 2011 | 39873 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2003 | 226 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1628 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 158 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3090 | 0.010 |
Why?
|
| Action Potentials | 1 | 2008 | 1816 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 6013 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1990 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 412 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 728 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 695 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 640 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 539 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 876 | 0.010 |
Why?
|
| Oxygen | 1 | 2011 | 4192 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2008 | 2533 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 597 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 867 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11471 | 0.010 |
Why?
|
| Focus Groups | 1 | 2004 | 1382 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 15785 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12262 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2003 | 1113 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1533 | 0.010 |
Why?
|
| Acting Out | 2 | 1987 | 16 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 5031 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6127 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5779 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3322 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39060 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3734 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15594 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2004 | 2215 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5781 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 2800 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5864 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8297 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1996 | 54136 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9575 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10747 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4485 | 0.010 |
Why?
|
| Curriculum | 1 | 2004 | 3717 | 0.010 |
Why?
|
| Neurons | 1 | 2008 | 9418 | 0.010 |
Why?
|
| Interpersonal Relations | 2 | 1987 | 1433 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7377 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 9468 | 0.000 |
Why?
|
| Paranoid Personality Disorder | 1 | 1985 | 7 | 0.000 |
Why?
|
| Manuals as Topic | 1 | 1986 | 99 | 0.000 |
Why?
|
| Aged | 2 | 1996 | 168217 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2008 | 23341 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 58808 | 0.000 |
Why?
|
| Schizotypal Personality Disorder | 1 | 1985 | 290 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 219560 | 0.000 |
Why?
|
| Borderline Personality Disorder | 1 | 1985 | 765 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2004 | 64379 | 0.000 |
Why?
|